Anticoagulant drugs with or without proton pump inhibitor and colorectal cancer risk: a population-based, case–control study

Abstract Background Low-dose aspirin and clopidogrel have demonstrated potential chemoprevention for colorectal cancer (CRC). Proton-pump inhibitors (PPI) are commonly prescribed with anticoagulation drugs, but the relationship between PPI and CRC is unclear. Moreover, evidence of CRC risk under dir...

Descripció completa

Dades bibliogràfiques

Autors principals:	Pei-Huan Ho, Hung-Chun Hsiao, Chun-Wei Chen, Hui-Ming Chen, Siew-Na Lim, Chau-Ting Yeh, Chia-Jung Kuo, Wey-Ran Lin
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2022-05-01
Col·lecció:	BMC Gastroenterology
Matèries:	Colorectal cancer Low-dose aspirin Clopidogrel Direct oral anticoagulant Proton pump inhibitor
Accés en línia:	https://doi.org/10.1186/s12876-022-02314-w
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!